# Nula Therapeutics, Inc. — Form D

Nula Therapeutics, Inc. of St. Petersburg, FL, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-18. The offering totals $7.4M, of which $7.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-03-18
- Form: D
- Accession: 0002121301-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.4M
- Amount sold: $7.4M
- Investors: 7
- Date of first sale: 2026-02-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-576919

## Issuer

- Name: Nula Therapeutics, Inc.
- CIK: 0002121301
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 961 Arlington Ave N, St. Petersburg, FL, 33705
- Phone: 212-392-4735

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Nils Regge | Director | St. Petersburg, FL |
| Jarod Rutledge | Director | St. Petersburg, FL |
| Christopher Shepard | Director | St. Petersburg, FL |
| Christopher Shepard | Executive Officer | St. Petersburg, FL |

## More

- [CIK 2121301 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2121301&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002121301-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.